{"id":974,"date":"2025-05-28T15:56:04","date_gmt":"2025-05-28T06:56:04","guid":{"rendered":"https:\/\/gucvmed.med.gunma-u.ac.jp\/?page_id=974"},"modified":"2025-05-28T15:56:04","modified_gmt":"2025-05-28T06:56:04","slug":"2024%e5%b9%b4%e3%80%80%e5%ad%a6%e4%bc%9a%e7%99%ba%e8%a1%a8","status":"publish","type":"page","link":"https:\/\/gucvmed.med.gunma-u.ac.jp\/?page_id=974","title":{"rendered":"2024\u5e74\u3000\u5b66\u4f1a\u767a\u8868"},"content":{"rendered":"
\n

\u7b2c25<\/span>\u56de\u65e5\u672c\u6210\u4eba\u5148\u5929\u6027\u5fc3\u75be\u60a3\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a2024.1.6-8<\/span>\uff08\u6771\u4eac\uff09<\/h4>\n
    \n
  1. \u5c0f\u677f\u6a4b\u7d00\u901a
    \n<\/span>\u598a\u5a20\u4e2d\u306b\u4e73\u304c\u3093\u306b\u96c6\u5b66\u7684\u6cbb\u7642\u3092\u884c\u3063\u305f\u30d5\u30a1\u30ed\u30fc\u56db\u5fb4\u75c7\u8853\u5f8c\u598a\u5a66\u306e\u4e00\u4f8b<\/li>\n
  2. \u5409\u7530\u304f\u306b\u5b50
    \n<\/span>\u8457\u660e\u306a\u53f3\u623f\u5316\u53f3\u5ba4\u3092\u4f34\u3046\u30a8\u30d6\u30b9\u30bf\u30a4\u30f3\u5947\u5f62\u598a\u5a66\u306e\u4e00\u4f8b<\/li>\n
  3. \u7530\u6751\u5cfb\u592a\u90ce
    \n<\/span>\u8853\u5f8c\u9060\u9694\u671f\u306b\u5de6\u5ba4\u6a5f\u80fd\u4e0d\u5168\u3001\u5b8c\u5168\u623f\u5ba4\u30d6\u30ed\u30c3\u30af\u3001\u5fc3\u5ba4\u7d30\u52d5\u3092\u5448\u3057\u305f\u30d5\u30a1\u30ed\u30fc\u56db\u5fb4\u75c7\u306e\u75c7\u4f8b<\/li>\n<\/ol>\n

    \u7b2c36<\/span>\u56de\u81e8\u5e8a\u4e0d\u6574\u8108\u7814\u7a76\u4f1a\u30002024.1.13<\/span>\uff08\u6771\u4eac\uff09<\/h4>\n

    \u7530\u6751\u5cfb\u592a\u90ce\u3001\u4e2d\u8c37\u6d0b\u4ecb\u3001\u5c0f\u91dd\u5c2d\u53f8\u3001\u9577\u8c37\u5ddd\u5bdb\u3001\u77f3\u4e95\u79c0\u6a39<\/p>\n

    Mahaim\u675f\u306b\u985e\u4f3c\u3059\u308b\u304c\u6e1b\u8870\u4f1d\u5c0e\u7279\u6027\u3092\u6709\u3055\u306a\u3044\u526f\u4f1d\u5c0e\u8def\u3092\u8a8d\u3081\u305f\uff11\u4f8b<\/p>\n

    \u65e5\u672c\u4e0d\u6574\u8108\u5fc3\u96fb\u5b66\u4f1a\u3000\u7b2c\uff14\u56de\u95a2\u6771\u7532\u4fe1\u8d8a\u652f\u90e8\u5730\u65b9\u4f1a\u30002024.1.20<\/span>\uff08\u6771\u4eac\uff09<\/h4>\n
      \n
    1. \u5c0f\u91dd\u5c2d\u53f8\u3001\u4e2d\u8c37\u6d0b\u4ecb\u3001\u7530\u6751\u5cfb\u592a\u90ce\u3001\u9577\u8c37\u5ddd\u5bdb\u3001\u77f3\u4e95\u79c0\u6a39\u3001\u6edd\u5ddd\u6b63\u6643<\/li>\n<\/ol>\n

      \u4e0d\u6574\u8108\u6e90\u6027\u53f3\u5ba4\u5fc3\u7b4b\u75c7\u306b\u304a\u3051\u308b\u4e09\u6b21\u5143\u56de\u8def\u3092\u5448\u3059\u308b\u5fc3\u5ba4\u983b\u62cd\u3092\u8a8d\u3081\u305f\uff11\u4f8b<\/p>\n

      2.\u91d1\u53e4\u5584\u660e\u3001\u7530\u6751\u5cfb\u592a\u90ce\u3001\u5c0f\u91dd\u5c2d\u53f8\u3001\u9577\u8c37\u5ddd\u5bdb\u3001\u4e2d\u8c37\u6d0b\u4ecb\u3001\u77f3\u4e95\u79c0\u6a39<\/p>\n

      Superior slow pathway\u306e\u4f1d\u5c0e\u6027\u3068AVNRT<\/span>\u767a\u75c7\u3068\u306e\u95a2\u9023<\/p>\n

      \u7b2c271<\/span>\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\u30002024.2.17<\/span>\uff08\u6771\u4eac\uff09<\/h4>\n
        \n
      1. \u77f3\u4e95\u79c0\u6a39
        \n<\/span>\u5404\u90fd\u770c\u306b\u3088\u308b\u5faa\u74b0\u5668\u75c5\u5bfe\u7b56\u63a8\u9032\u306e\u53d6\u308a\u7d44\u307f\uff1a\u7b2c2<\/span>\u671f\u306b\u5411\u3051\u3066\u2015\u7fa4\u99ac\u770c\u306e\u53d6\u308a\u7d44\u307f\u2015<\/li>\n
      2. \u5c0f\u4fdd\u65b9\u3000\u512a
        \nHFpEF<\/span>\u306e\u904b\u52d5\u8ca0\u8377\u306e\u3044\u308d\u306f<\/li>\n
      3. \u8c37\u3000\u53cb\u592a
        \n<\/span>\u65e9\u671fHFpEF<\/span>\u60a3\u8005\u306e\u6804\u990a\u72b6\u614b\u306e\u9055\u3044\u304c\u4e88\u5f8c\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306e\u691c\u8a0e<\/li>\n<\/ol>\n

        \u7b2c88<\/span>\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08JCS2024<\/span>\uff092024.3.8-10<\/span>\uff08\u795e\u6238\uff09<\/h4>\n

        3\/8<\/p>\n

          \n
        1. \u9ad8\u9593\u5178\u660e
          \n<\/span>\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff13\u300c\u80ba\u9ad8\u8840\u5727\u75c7\u306e\u65b0\u5b9a\u7fa9\u3092\u8e0f\u307e\u3048\u305f\u75c5\u614b\u8a55\u4fa1\u3068\u6cbb\u7642\u6226\u7565\u300d
          \nEarly Therapeutic Intervention Based on Real-world Data of Relationship between Treatment for Pulmonary Arterial Hypertension and Thyroid Gland Malfunction<\/span><\/li>\n
        2. \u6e6f\u6d45\u76f4\u7d00
          \n<\/span>\u52b4\u4f5c\u6642\u606f\u5207\u308c\u3092\u5448\u3059\u308b\u3001HF<\/span>\uff50EF<\/span>\u3092\u5408\u4f75\u3057\u305f\u5f37\u76ae\u75c7\u60a3\u8005\u306e\u81e8\u5e8a\u7684\u80cc\u666f<\/li>\n
        3. \u5c0f\u4fdd\u65b9\u3000\u512a
          \n<\/span>\u5fc3\u4e0d\u5168\u306e\u8a3a\u65ad\u30fb\u6cbb\u7642\u306b\u304a\u3051\u308b\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u56f3\u306e\u5f79\u5272<\/li>\n
        4. \u5929\u5185\u58eb\u90ce
          \nA Case of Exercise Induced Severe Functional Mitral Regurgitation: the Efficacy of Exercise Stress Catheterization and Transcatheter Mitral Valve Repair<\/span><\/li>\n
        5. \u5c0f\u4fdd\u65b9\u3000\u512a
          \n<\/span>\u6d77\u5916\u7559\u5b66\u30cd\u30c3\u30c8\u30ef\u30fc\u30ad\u30f3\u30b0\u30bb\u30df\u30ca\u30fc<\/li>\n
        6. \u524d\u6a4b\u8d64\u5341\u5b57\u75c5\u9662\u3000\u5cef\u5cb8\u7f8e\u667a\u5b50
          \nOutcome of 194 Syncope Patients with ICM Implantation over 13 Years at Our Hospital\u00a0<\/span><\/li>\n
        7. \u4e45\u91ce\u8cb4\u5f18
          \nActual Management of Venous Thromboembolism in Patients with Terminal Cancer. from the COMMAND-VTE Registry-2<\/span><\/li>\n
        8. \u93e1\u3000\u548c\u6a39
          \nCharacterization of Atrial Functional Mitral Regurgitation in Heart Failure with Preserved Ejection Fraction<\/span><\/li>\n
        9. \u5c0f\u677f\u6a4b\u7d00\u901a
          \n<\/span>\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 13<\/span>\u300c\u5faa\u74b0\u5668\u533b\u3001\u3042\u306a\u305f\u304c\u7537\u6027\u306a\u3089\u3069\u3046\u3059\u308b\uff1f\u5973\u6027\u306a\u3089\u3069\u3046\u3059\u308b\uff1f\uff0d\u516c\u958b\u30c7\u30a3\u30d9\u30fc\u30c8\u300d
          \nHow Should the “Ikyoku” Responsible for Community Medicinal Care be Staffed with Female Physicians in Diversity Era?<\/span><\/li>\n
        10. \u4e2d\u8c37\u6d0b\u4ecb
          \nCharacteristics of Localized-reentrant Atrial Tachycardia Using the Coronary Sinus as a Tachycardia Circuit<\/span><\/li>\n
        11. \u91d1\u53e4\u5584\u660e
          \nA Role of Compact Node for the Induction and Sustenance of Slow-Fast Atrioventricular Nodal Reentrant Tachycardia<\/span><\/li>\n
        12. \u91d1\u53e4\u5584\u660e
          \nIdentification of an Orthodromic Capture during Atrial Entrainment by Comparing with an Antidromic Capture<\/span><\/li>\n
        13. \u4e2d\u91ce\u8003\u82f1
          \nSuccessful Switching from Continuous Intravenous Infusion of Treprostinil to Inhaled Treprostinil for Patient with Idiopathic Pulmonary Arterial Hypertension<\/span><\/li>\n
        14. \u7530\u6751\u5cfb\u592a\u90ce
          \nNo Exact Reproducibility of a Retrograde Atrial Activation during Slow-Fast Atrioventricular Nodal Reentrant Tachycardia with Programed Ventricular Stimulation<\/span><\/li>\n
        15. \u5c0f\u4fdd\u65b9\u3000\u512a
          \nCirculation: Cardiovascular Imaging -Editor’s Picks for 2023<\/span><\/li>\n
        16. Nakajima T,Tamura S,Hasegawa H,Kobari T,Kurabayashi M,Kaneko Y,Horie M,Nakatani Y,Ishii H
          \nUnique Gating Abnormalities of IKs <\/sub>Caused by a Novel KCNQ<\/em>1Voltage-Sensor Mutation,Q234K,Identified in Patients with Long QT Syndrome<\/li>\n
        17. \u5ead\u524d\u91ce\u83ca
          \n<\/span>Efficacy of Cardiac Sympathetic Denervation for Refractory Vasospastic Angina and its Effect on Autonomic Function<\/li>\n<\/ol>\n

          \u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u7b2c\uff13\uff15\u56de\u5b66\u8853\u96c6\u4f1a\u30002024.4.19-21<\/span>\uff08\u59eb\u8def\uff09<\/h4>\n
            \n
          1. \u5c0f\u4fdd\u65b9\u512a
            \n<\/span>\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff5e\u5fc3\u4e0d\u5168\u6cbb\u7642\u306b\u5fc3\u30a8\u30b3\u30fc\u56f3\u6cd5\u3092\u6d3b\u304b\u3059\uff5e\u300c\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u3092\u4f7f\u3063\u305fHEpEF<\/span>\u306e\u65e9\u671f\u8a3a\u65ad\uff5e\u606f\u5207\u308c\u5916\u6765\u306e\u7d4c\u9a13\u304b\u3089\uff5e\u300d<\/li>\n
          2. \u6751\u4e0a\u6587\u5d07 \u3001\u6e6f\u6d45\u76f4\u7d00 \u3001\u539f\u7530\u667a\u6210 \u3001\u53cd\u753a\u79c0\u7f8e \u3001\u52a0\u85e4\u5bff\u5149 \u3001\u77f3\u4e95\u79c0\u6a39 \u3001\u5c0f\u4fdd\u65b9\u512a
            \nHFpEF<\/span>\u60a3\u8005\u306b\u304a\u3051\u308b\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u6642\u306e\u8840\u5727\u4e0a\u6607\u306e\u6a5f\u5e8f\u3068\u4e88\u5f8c\u3078\u306e\u5f71\u97ff\u306e\u691c\u8a0e<\/li>\n
          3. \u5c0f\u4fdd\u65b9\u512a
            \n<\/span>\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff5e\u3082\u3063\u3068\u6df1\u5800\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u56f3\uff5e\u300cHEpEF<\/span>\u306e\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u306e\u30d4\u30c3\u30c8\u30db\u30fc\u30eb\uff1aHEpEF<\/span>\u3092\u3069\u3046\u3084\u3063\u3066\u8a3a\u65ad\u3057\u307e\u3059\u304b\uff1f\u300d<\/li>\n
          4. \u5c0f\u4fdd\u65b9\u512a
            \n<\/span>\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff5e\u80ba\u9ad8\u8840\u5727\u75c7\u306e\u5fc3\u30a8\u30b3\u30fc\u56f3\u8a55\u4fa1\u3092\u6539\u3081\u3066\u8003\u3048\u308b\uff5e\u300c\u5f37\u76ae\u75c7\u60a3\u8005\u306b\u304a\u3051\u308b\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u306e\u53ef\u80fd\u6027\u300d<\/li>\n
          5. \u5c0f\u4fdd\u65b9\u512a
            \n<\/span>\u6559\u80b2\u59d4\u54e1\u4f1a\u4f01\u753b\uff12\uff5e\u30de\u30eb\u30c1\u30e2\u30c0\u30ea\u30c6\u30a3\u6642\u4ee3\u306b\u304a\u3051\u308b\u5fc3\u30a8\u30b3\u30fc\u56f3\u306e\u7acb\u3061\u4f4d\u7f6e\uff5e\u300cHEpEF<\/span>\u8a3a\u65ad\u306e\u305f\u3081\u306e\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u56f3\u306e\u5f79\u5272\u3068\u8ab2\u984c\u300d<\/li>\n
          6. \u6e6f\u6d45\u76f4\u7d00
            \n<\/span>\u6f5c\u5728\u7684\u306a\u5de6\u5ba4\u62e1\u5f35\u969c\u5bb3\u3092\u5408\u4f75\u3057\u305f\u5f37\u76ae\u75c7\u60a3\u8005\u306e\u81e8\u5e8a\u7684\u610f\u7fa9<\/li>\n<\/ol>\n

            \u5fc3\u96fb\u5b66\u95a2\u9023\u6625\u5b63\u5927\u4f1a2024<\/span>\u30002024.4.20<\/span>\uff08\u5927\u5206\uff09<\/h4>\n

            \u4e2d\u8c37\u6d0b\u4ecb<\/p>\n

            \u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff1a\u9577\u671f\u9593\u30db\u30eb\u30bf\u30fcAT-Patch<\/span>\u3092\u4e0d\u6574\u8108\u8a3a\u7642\u306b\u6d3b\u7528\u3059\u308b\u300c\u96a0\u308c\u305f\u4e0d\u6574\u8108\u3092\u3042\u3076\u308a\u3060\u3059\uff5eAT-Patch<\/span>\u306e\u6709\u7528\u6027\uff5e\u300d<\/p>\n

            Heart Rhythm Scientific Sessions 2024\u30002024.5.16-19<\/span>\uff08Boston<\/span>\uff09<\/h4>\n
              \n
            1. Nakatani Y, Take Y, Takizawa R, Goto K, Kaseno K, Yoshimura S, Haraguchi Y, Kimura K, Sasaki T, Miki Y, Nakamura K, Naito S.<\/li>\n
            2. Effectiveness of systematic ablation targeting epicardial connection sites for right pulmonary vein isolation in atrial fibrillation cases.<\/li>\n
            3. Nakatani Y, Take Y, Takizawa R, Kaseno K, Goto K, Yoshimura S, Haraguchi Y, Sasaki T, Miki Y, Kimura K, Nakamura K, Naito S.<\/li>\n
            4. Distinguishing atrial tachycardia from supraventricular tachycardia using paraHisian single extra-stimulation.<\/li>\n<\/ol>\n

              \u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a\u7b2c97<\/span>\u56de\u5b66\u8853\u96c6\u4f1a\u30002024.5.31-6.2<\/span>\uff08\u6a2a\u6d5c\uff09<\/h4>\n
                \n
              1. \u5c0f\u4fdd\u65b9\u512a
                \n<\/span>\u6559\u80b2\uff1a\u6b21\u4e16\u4ee3\u3078\u305f\u304f\u3059\u5fc3\u30a8\u30b3\u30fc<\/li>\n
              2. \u5c0f\u4fdd\u65b9\u512a
                \n<\/span>HF\uff50EF<\/span>\u306e\u81e8\u5e8a\u7684\u591a\u69d8\u6027\u306b\u5fc3\u30a8\u30b3\u30fc\u3092\u6d3b\u304b\u3059<\/li>\n<\/ol>\n

                \u7b2c272<\/span>\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\u30002024.6.1<\/span>\uff08\u6771\u4eac\uff09<\/h4>\n
                  \n
                1. \u77f3\u4e95\u79c0\u6a39
                  \n<\/span>\u6559\u80b2\u30bb\u30c3\u30b7\u30e7\u30f3\uff1aACS<\/span>\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\uff5eACS<\/span>\u75c7\u4f8b\u306b\u304a\u3051\u308b\u4e8c\u6b21\u4e88\u9632\u306e\u91cd\u8981\u6027\uff5e<\/li>\n
                2. \u5b89\u9054\u4ec1
                  \n<\/span>\u30b9\u30dd\u30fc\u30c4\u533b\u5b66\u3068\u5fc3\u81d3\u30ea\u30cf\u30d3\u30ea\u306e\u878d\u5408\uff5e\u5fc3\u4e0d\u5168\u306e\u9aa8\u683c\u7b4b\u3068\u904b\u52d5\u7642\u6cd5<\/li>\n
                3. \u77f3\u6a4b\u6d0b\u5e73\u3001\u91ce\u5c3b\u7fa9\u4eba\u3001\u702c\u7530\u535a\u8cb4\u3001\u9ad8\u6a4b\u6d0b\u53f3\u3001\u5343\u5409\u826f\u5f69\u82b1\u3001\u67f4\u5d0e\u609f\u3001\u7fbd\u9ce5\u76f4\u6a39\u3001\u9ad8\u6a4b\u4f38\u5f25\u3001\u6751\u7530\u667a\u884c\u3001\u5c0f\u6797\u7d18\u751f\u3001\u592a\u7530\u660c\u6a39\u3001\u798f\u7530\u5ef6\u662d\u3001\u5e83\u4e95\u77e5\u6b73
                  \n<\/span>\u98a8\u75b9\u306b\u3088\u308b\u6025\u6027\u5fc3\u819c\u5fc3\u7b4b\u708e\u3068\u5fc3\u30bf\u30f3\u30dd\u30ca\u30fc\u30c7\u306e\uff11\u4f8b<\/li>\n
                4. \u771f\u6728\u82bd\u4ee5\u3001\u9060\u85e4\u8def\u5b50\u3001\u85e4\u4e95\u5b5d\u6210\u3001\u795e\u5d0e\u7db1\u3001\u65b0\u6728\u7fa9\u5f18\u3001\u658e\u85e4\u7ae0\u5b8f\u3001\u6e05\u6c34\u5cb3\u4e45\u3001\u65b0\u4e95\u660c\u53f2
                  \n<\/span>\u6162\u6027\u8840\u6813\u585e\u6813\u6027\u80ba\u9ad8\u8840\u5727\u75c7\u3067\u901a\u9662\u4e2d\u306b\u9855\u5fae\u93e1\u7684\u591a\u767a\u8840\u7ba1\u708e\u306e\u8a3a\u65ad\u306b\u81f3\u3063\u305f1<\/span>\u4f8b<\/li>\n<\/ol>\n

                  \u7b2c54<\/span>\u56de\u81e8\u5e8a\u5fc3\u81d3\u96fb\u6c17\u751f\u7406\u7814\u7a76\u4f1a\u30002024.6.8<\/span>\uff08\u5317\u4e5d\u5dde\uff09<\/h4>\n

                  \u91d1\u53e4\u5584\u660e\u3001\u7530\u6751\u5cfb\u592a\u90de\u3001\u5c0f\u91dd\u5c2d\u53f8\u3001\u9577\u8c37\u5ddd\u5bdb\u3001\u4e2d\u8c37\u6d0b\u4ecb\u3001\u77f3\u4e95\u79c0\u6a39<\/p>\n

                  Superior-type fast-slow AVNRT\u306b\u5bfe\u3059\u308b\u5fc3\u623f\u30a8\u30f3\u30c8\u30ec\u30a4\u30f3\u30e1\u30f3\u30c8\u4e2d\u306b\u8208\u5473\u3042\u308b\u5fc3\u5ba4\u5468\u671f\u306e\u5909\u52d5\u304c\u89b3\u5bdf\u3055\u308c\u305f\u4e00\u4f8b\uff0e<\/p>\n

                  \u7b2c69<\/span>\u56de\u65e5\u672c\u900f\u6790\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a\u30002024.6.7-9<\/span>\uff08\u6a2a\u6d5c\uff09<\/h4>\n
                    \n
                  1. \u5c0f\u4fdd\u65b9\u512a
                    \n<\/span>\u900f\u6790\u60a3\u8005\u306eHFpEF<\/span>\u306e\u75c5\u614b\u30fb\u6cbb\u7642\u306b\u8feb\u308b<\/li>\n
                  2. \u77f3\u4e95\u79c0\u6a39
                    \n<\/span>\u900f\u6790\u60a3\u8005\u306b\u304a\u3051\u308b\u51a0\u52d5\u8108\u75be\u60a3\uff5e\u51a0\u8840\u884c\u518d\u5efa\u8853\u304b\u4fdd\u5b58\u7684\u52a0\u7642\u304b\uff1f\uff5e<\/li>\n<\/ol>\n

                    \u7b2c63<\/span>\u56de\u57fc\u7389\u4e0d\u6574\u8108\u307a\u30fc\u30b7\u30f3\u30b0\u7814\u7a76\u4f1a\u30002024.6.15<\/span>\uff08\u3055\u3044\u305f\u307e\uff09<\/h4>\n

                    \u7530\u6751\u5cfb\u592a\u90ce\u3001\u4e2d\u8c37\u6d0b\u4ecb\u3001\u9577\u8c37\u5ddd\u5bdb\u3001\u5c0f\u91dd\u582f\u53f8\u3001\u77f3\u4e95\u79c0\u6a39\u3001\u91d1\u53e4\u5584\u660e<\/p>\n

                    \u5fc3\u623f\u9023\u7d9a\u523a\u6fc0\u4e2d\u306b\u547c\u5438\u306b\u540c\u671f\u3057\u3066\u623f\u5ba4\u7d50\u7bc0\u901f\u4f1d\u5c0e\u8def\u3068\u9045\u4f1d\u5c0e\u8def\u306e\u9593\u3067\u306e\u4e57\u308a\u63db\u3048\u3092\u7e70\u308a\u8fd4\u3057\u305f1<\/span>\u4f8b<\/p>\n

                    \u7b2c\u00a035\u00a0<\/span>\u56de\u4e21\u6bdb\u4e0d\u6574\u8108\u30bb\u30df\u30ca\u30fc\u30002024.6.15<\/span>\uff08Web<\/span>\uff09<\/h4>\n

                    \u5c0f\u91dd \u5c2d\u53f8\u3001\u4e2d\u8c37 \u6d0b\u4ecb\u3001\u7530\u6751 \u5cfb\u592a\u90ce\u3001\u9577\u8c37\u5ddd \u5bdb\u3001\u77f3\u4e95 \u79c0\u6a39\u3001\u91d1\u53e4 \u5584\u660e<\/p>\n

                    2\u00a0\u3064\u306e\u5fc3\u623f\u5074\u4ed8\u7740\u7aef\u3092\u6709\u3059\u308b\u623f\u5ba4\u7d50\u7bc0\u9045\u4f1d\u5c0e\u8def\u306b\u3088\u308b\u975e\u901a\u5e38\u578b\u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\u00a01\u00a0<\/span>\u4f8b<\/p>\n

                    TOPIC2024\u30002024.7.11-13<\/span>\uff08\u6771\u4eac\uff09<\/h4>\n
                      \n
                    1. \u5929\u5185\u58eb\u90ce
                      \nRCA\u5165\u53e3\u90e8\u306e\u9ad8\u5ea6\u77f3\u7070\u5316\u3092\u4f34\u3046\u30b9\u30c6\u30f3\u30c8\u5185\u518d\u72ed\u7a84\u306b\u5bfe\u3057\u3066Rotablator<\/span>\u3092\u6210\u529f\u3057\u305f1<\/span>\u4f8b<\/li>\n
                    2. \u5ead\u524d\u91ce\u83ca\uff08\u30b3\u30e1\u30f3\u30c6\u30fc\u30bf\u30fc\uff09
                      \nJ-WINC @ TOPIC Part 1 Video Live <\/span>\u77f3\u7070\u5316\u3068\u5c48\u66f2\u3092\u4f34\u3063\u305f\u30c0\u30d6\u30ebLAD<\/span>\u306e\u75c7\u4f8b
                      \nJ-WINC @ TOPIC Part 2 <\/span>\u75c7\u4f8b\u691c\u8a0e\u4f1a<\/li>\n
                    3. \u5ead\u524d\u91ce\u83ca\uff08\u30b3\u30e1\u30f3\u30c6\u30fc\u30bf\u30fc\uff09
                      \nPCI Live Demonstration 8<\/span><\/li>\n
                    4. \u5929\u5185\u58eb\u90ce\uff08\u30d1\u30cd\u30ea\u30b9\u30c8\uff09
                      \n\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff1a\u6162\u6027\u5b8c\u5168\u9589\u585e\uff08CTO)<\/span><\/li>\n<\/ol>\n

                      \u7b2c70<\/span>\u56de\u65e5\u672c\u4e0d\u6574\u8108\u5fc3\u96fb\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30002024.7.18-20<\/span>\uff08\u91d1\u6ca2\uff09<\/h4>\n
                        \n
                      1. \u4e2d\u5cf6\u5fe0
                        \n<\/span>\u82e5\u624b\u6559\u80b2\u30bb\u30c3\u30b7\u30e7\u30f3\uff1a\u521d\u3081\u3066\u307f\u308b\u907a\u4f1d\u6027\u4e0d\u6574\u8108<\/li>\n
                      2. \u4e2d\u5cf6\u5fe0
                        \nOral Presentation 25<\/span>\uff1aBasic, Genetic and Pathophysiology<\/span><\/li>\n
                      3. Tamura S.,Nakatani Y.,Kobari T.,Hasegawa H.,Soga J.,Sano M.,Obokata M.,Ishii H
                        \nCharacteristics of structural remodeling in atrial fibrillation patients with heart failure with preserved ejection fraction.<\/li>\n
                      4. Hasegawa H.,Nakatani Y.,Kobari T.,Tamura S.,Ishi H.
                        \nComputed tomographic predictors for electrogram amplitude in subcutaneous implantable cardioverter-defibrillators.<\/li>\n
                      5. Nakajima T.,Hasegawa H.,Tamura S.,Kobari T.,Matsumoto N.,Sano Y.,Kurabayashi K.,Kaneko Y.,Nakatani Y.,Ishii H.
                        \nDiverse phenotypic manifestations in a family with a novel RYR2 E4107A variant.<\/li>\n<\/ol>\n

                        \u65e5\u672c\u5fc3\u8840\u7ba1\u30a4\u30f3\u30bf\u30fc\u30d9\u30f3\u30b7\u30e7\u30f3\u6cbb\u7642\u5b66\u4f1a\u30002024.7.25-27<\/span>\uff08\u672d\u5e4c\uff09<\/h4>\n
                          \n
                        1. \u5929\u5185\u58eb\u90ce
                          \n<\/span>ACS\u306e\u975e\u8cac\u4efb\u75c5\u5909\u306b\u5bfe\u3057\u3066\u5b89\u9759\u6642\u6307\u6a19\u3092\u6e2c\u5b9a\u3057defer<\/span>\u3057\u305f\u304c\uff0c6<\/span>\u9031\u5f8c\u306b\u540c\u75c5\u5909\u3092\u8cac\u4efb\u75c5\u5909\u3068\u3059\u308b2<\/span>\u56de\u76ee\u306eACS<\/span>\u3092\u767a\u75c7\u3057\u305f1<\/span>\u4f8b<\/span><\/li>\n
                        2. \u77f3\u4e95\u79c0\u6a39
                          \n\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff12\uff13\uff1a\u75c5\u6b74\u8074\u53d6\u304b\u3089\u59cb\u307e\u308b\u72ed\u5fc3\u75c7\u8a3a\u65ad<\/li>\n
                        3. \u5c0f\u6797\u6d0b\u660e
                          \nA case of SFA in-stent occlusion large amount of thrombus effectively aspirated and observed with angioscopy<\/span><\/li>\n
                        4. \u85e4\u4e95 \u5b5d\u6210
                          \n\u5fc3\u539f\u6027\u30b7\u30e7\u30c3\u30af\u3092\u5448\u3057\u6a5f\u68b0\u7684\u88dc\u52a9\u5faa\u74b0\u304c\u4f7f\u7528\u56f0\u96e3\u306a\u304b\u3067\u6700\u5c0f\u9650\u306ePCI<\/span>\u3067\u4e57\u308a\u8d8a\u3048\u305f\u4e00\u4f8b<\/li>\n
                        5. \u7acb\u5d0e\u5065\u4e00\u3001\u5411\u7b20\u826f\u5b8f\u3001\u9ad9\u6a4b\u516c\u5fb3\u3001\u571f\u5c4b\u5bdb\u5b50\u3000\u3001\u4e2d\u91ce\u660e\u5f66
                          \nLMT\u306b\u5bfe\u3059\u308bDCA-DCB<\/span>\u306e\u6cbb\u7642\u6210\u7e3e<\/li>\n
                        6. \u571f\u5c4b\u5bdb\u5b50
                          \n\u900f\u6790\u60a3\u8005\u306b\u304a\u3051\u308bcalcified nodule<\/span>\u306b\u5bfe\u3059\u308b\u6700\u9069\u306aPCI<\/span>\u6cbb\u7642\u6226\u7565\u306f\u4f55\u304b\uff1fWhat is the optimal treatment PCI strategy for calcified nodules in cases of hemodialysis?<\/li>\n
                        7. \u77f3\u4e95\u79c0\u6a39
                          \n\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff16\uff1aPCI<\/span>\u306e\u30ea\u30a2\u30eb\u30ef\u30fc\u30eb\u30c9\u30fb\u30a8\u30d3\u30c7\u30f3\u30b9<\/li>\n
                        8. \u77f3\u4e95\u79c0\u6a39
                          \n\u30a2\u30ab\u30c7\u30df\u30c3\u30af\u30b5\u30dd\u30fc\u30c8\u7814\u7a76\u767a\u8868\u30fb\u30b3\u30e1\u30f3\u30c6\u30fc\u30bf\u30fc<\/li>\n
                        9. Kazufumi Aihara, Shunsuke Higa, Michito Tani
                          \nTreatment Strategies and Outcomes of Patients with Acute Coronary Syndrome Requiring Cardiac Surgery on Remote Islands without Cardiac Surgical Facilities(\u5fc3\u81d3\u5916\u79d1\u8a2d\u5099\u306e\u306a\u3044\u96e2\u5cf6\u306b\u304a\u3051\u308b\u3001\u5fc3\u81d3\u5916\u79d1\u624b\u8853\u304c\u5fc5\u8981\u306a\u91cd\u75c7ACS<\/span>\u60a3\u8005\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u6226\u7565\u3068\u8ee2\u5e30)<\/span><\/li>\n
                        10. Kazufumi Aihara, Shunsuke Higa, Michito Tani
                          \nEpidemiological Investigation of Patients Requiring Percutaneous Coronary Intervention for Acute Coronary Syndrome in Remote Islands(\u96e2\u5cf6\u306b\u304a\u3051\u308b\u3001ACS<\/span>\u306b\u5bfe\u3059\u308bPCI<\/span>\u304c\u5fc5\u8981\u3068\u3055\u308c\u308b\u60a3\u8005\u306b\u95a2\u3059\u308b\u75ab\u5b66\u8abf\u67fb)<\/span><\/li>\n
                        11. \u6e21\u9089 \u771f
                          \n<\/span>\u6025\u6027\u51a0\u75c7\u5019\u7fa4\u3092\u767a\u75c7\u3057\u8840\u884c\u518d\u5efa\u76ee\u7684\u306b\u6297\u8840\u5c0f\u677f\u85ac\u5c0e\u5165\u5f8c\u3001\u80ba\u80de\u51fa\u8840\u3092\u5408\u4f75\u3057\u305f2<\/span>\u4f8b<\/li>\n
                        12. \u77f3\u4e95\u79c0\u6a39
                          \n\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff1a\u865a\u8840\u6027\u5fc3\u75be\u60a3\u3092\u5408\u4f75\u3057\u305f2<\/span>\u578b\u7cd6\u5c3f\u75c5\u60a3\u8005\u306e\u6cbb\u7642\u3092\u8003\u3048\u308b\u30fcGLP-1<\/span>\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\u3078\u306e\u671f\u5f85\u30fc<\/li>\n<\/ol>\n

                          ESC Congress 2024\u30002024.8.30-9.2<\/span>\uff08\u30ed\u30f3\u30c9\u30f3\uff09<\/h4>\n
                            \n
                          1. Masaru Obokata
                            \nESC-JCS joint symposium
                            \nStress echocardiography for diagnosis and risk stratification in HFpEF<\/li>\n
                          2. Yuta Tani
                            \nDiagnosis of heart failure with preserved ejection fraction based on exercise stress echoracdiography in real-world practice<\/li>\n<\/ol>\n

                            \u7b2c7<\/span>\u56de\u65e5\u672c\u816b\u760d\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002024.8.3-4<\/span>\uff08\u59eb\u8def\uff09<\/h4>\n
                              \n
                            1. \u6751\u4e0a\u6587\u5d07
                              \n\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB<\/span>\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e\u5fc3\u5185\u75c5\u5909\u306b\u5bfe\u3057\u3066MR-CHOP<\/span>\u7642\u6cd5\u304c\u8457\u52b9\u3057\u305f\u4e00\u4f8b<\/li>\n
                            2. \u5c0f\u677f\u6a4b\u7d00\u901a
                              \n\u304c\u3093\u306e\u69d8\u3005\u306a\u30b9\u30c6\u30fc\u30b8\u3067\u898b\u305f\u591a\u8077\u7a2e\u9023\u643a\u30c1\u30fc\u30e0\u3068\u3057\u3066\u306e\u5faa\u74b0\u5668\u5185\u79d1\u533b\u306e\u5f79\u5272\uff5e\u75c7\u4f8b\u3092\u901a\u3057\u3066\u591a\u304f\u306e\u5408\u4f75\u75c7\u3092\u62b1\u3048\u305f\u304c\u3093\u60a3\u8005\u306e\u6cbb\u7642\u3092\u8003\u3048\u308b\uff5e<\/li>\n<\/ol>\n

                              \u7b2c273<\/span>\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\u30002024.9.7<\/span>\uff08\u6771\u4eac\uff09<\/h4>\n
                                \n
                              1. \u5c71\u6751\u6210\u6176\u3001\u8c37\u3000\u53cb\u592a\u3001\u6e6f\u6d45\u76f4\u7d00\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u6751\u4e0a\u6587\u5d07\u3001\u52a0\u85e4\u5bff\u5149\u3001\u77f3\u4e95\u79c0\u6a39\u3001\u5c0f\u4fdd\u65b9\u512a
                                \n<\/span>\u5de6\u5ba4\u99c6\u51fa\u7387\u306e\u4fdd\u305f\u308c\u305f\u5fc3\u4e0d\u5168\u306b\u304a\u3051\u308b\u904b\u52d5\u6642\u306e\u53f3\u623f\u5727\u4e0a\u6607\u306e\u81e8\u5e8a\u7684\u610f\u7fa9<\/li>\n
                              2. \u6751\u4e0a\u6587\u5d07\u3001\u539f\u7530\u667a\u6210\u3001\u52a0\u85e4\u5bff\u5149\u3001\u6e6f\u6d45\u76f4\u7d00\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u77f3\u4e95\u79c0\u6a39\u3001\u5c0f\u4fdd\u65b9\u512a
                                \n<\/span>\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u3092\u7528\u3044\u305fHFpEF<\/span>\u60a3\u8005\u306e\u904b\u52d5\u8ca0\u8377\u6642\u306e\u8840\u5727\u4e0a\u6607\u306e\u6a5f\u5e8f\u3068\u4e88\u5f8c\u3078\u306e\u5f71\u97ff\u306e\u89e3\u6790<\/li>\n
                              3. \u7530\u53e3\u54f2\u4e5f
                                \nPAD<\/span>\u6cbb\u7642\u3068\u5730\u57df\u9023\u643a\u306b\u3064\u3044\u3066\uff5eCLTI<\/span>\u6cbb\u7642\u3068\u5730\u57df\u9023\u643a\u300c\u5f53\u9662\u306e\u7403\u80a2\u6cbb\u7642\u6226\u7565\u300d<\/li>\n
                              4. Batgerel Naidankhuu
                                \n\u52b4\u4f5c\u6642\u606f\u5207\u308c\u306e\u9451\u5225\uff5e\u606f\u5207\u308c\u5916\u6765\u306e\u75c7\u4f8b\uff5e<\/li>\n
                              5. \u6e6f\u6d45\u76f4\u7d00\u3001\u5c0f\u4fdd\u65b9\u512a\u3001\u6751\u4e0a\u6587\u5d07\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u52a0\u85e4\u5bff\u5149\u3001\u77f3\u4e95\u79c0\u6a39
                                \n<\/span>\u672b\u68a2\u9759\u8108\u5727\u4f75\u7528\u306e\u904b\u52d5\u8ca0\u8377\u5fc3\u30a8\u30b3\u30fc\u304c\u6ef2\u51fa\u6027\u53ce\u7e2e\u6027\u5fc3\u819c\u708e\u306e\u8a3a\u65ad\u306b\u6709\u52b9\u3067\u3042\u3063\u305fMimic HEpEF<\/span>\u306e\u4e00\u4f8b<\/li>\n
                              6. \u9ad8\u6a4b\u4f38\u5f25\u3001\u98ef\u585a\u62d3\u5df3\u3001\u4f50\u85e4\u65b0\u4e4b\u4ecb\u3001\u702c\u7530\u535a\u8cb4\u3001\u5927\u99d2\u76f4\u4e5f\u3001\u67f4\u7530\u3000\u609f\u3001\u7fbd\u9ce5\u76f4\u6a39\u3001\u5c0f\u6797\u7d18\u751f\u3001\u6751\u7530\u667a\u884c\u3001\u592a\u7530\u660c\u6a39\u3001\u798f\u7530\u5ef6\u662d\u3001\u5e83\u4e95\u77e5\u6b73
                                \n<\/span>\u6d1e\u6027\u983b\u8108\u3092\u4f34\u3046HFworEF<\/span>\u75c7\u4f8b\u306b\u5bfe\u3057\u3066CPAP<\/span>\u3068\u30a4\u30d0\u30d6\u30e9\u30b8\u30f3\u304c\u6709\u52b9\u3067\u3042\u3063\u305f1<\/span>\u4f8b<\/li>\n
                              7. \u6e6f\u6d45\u76f4\u7d00\u3001\u5c0f\u4fdd\u65b9\u512a\u3001\u6751\u4e0a\u6587\u5d07\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u52a0\u85e4\u5bff\u5149\u3001\u77f3\u4e95\u79c0\u6a39
                                \nHFpEF<\/span>\u60a3\u8005\u306e\u904b\u52d5\u8010\u5bb9\u80fd\u3068\u3001\u81e8\u5e8a\u7684\u80cc\u666f\u30fb\u4e88\u5f8c\u306e\u95a2\u4fc2
                                \n<\/span>\u6d1e\u6027\u983b\u8108\u3092\u4f34\u3046HFworEF<\/span>\u75c7\u4f8b\u306b\u5bfe\u3057\u3066CPAP<\/span>\u3068\u30a4\u30d0\u30d6\u30e9\u30b8\u30f3\u304c\u6709\u52b9\u3067\u3042\u3063\u305f\uff11\u4f8b<\/li>\n
                              8. \u4e0a\u7fbd\u3000\u5353\u3001\u5409\u6751\u771f\u543e\u3001\u7d48\u91ce\u5065\u4e00\u3001\u83c5\u91ce\u5e78\u592a\u3001\u8fd1\u85e4\u3000\u4f83\u3001\u7530\u4e2d\u4fca\u6b21\u3001\u5150\u7389\u4e9c\u5e0c\u5b50\u3001\u5897\u5c71\u5927\u6a39\u3001\u677e\u5c3e\u4f51\u6cbb\u3001\u4f50\u3005\u6728\u5065\u4eba\u3001\u897f\u5185\u3000\u82f1\u3001\u7f8e\u8f1d\u7950\u5b50\u3001\u4e2d\u6751\u7d18\u898f\u3001\u5185\u85e4\u6ecb\u4eba
                                \n<\/span>\u7d4c\u30ab\u30c6\u30fc\u30c6\u30eb\u7684\u5927\u52d5\u8108\u5f01\u7f6e\u63db\u8853\u5f8c\u306b\u623f\u5ba4\u63a5\u5408\u90e8\u983b\u62cd\u3092\u8a8d\u3081\u305f\u4e00\u4f8b<\/li>\n
                              9. \u7530\u4e2d\u4fca\u6b21\u3001\u4f50\u3005\u6728\u5065\u4eba\u3001\u4e2d\u6751\u7d18\u898f\u3001\u4e0a\u7fbd\u3000\u5353\u3001\u5150\u7389\u4e9c\u5e0c\u5b50\u3001\u5897\u5c71\u5927\u6a39\u3001\u677e\u5c3e\u4f51\u6cbb\u3001\u5409\u6751\u771f\u543e\u3001\u897f\u5185\u3000\u82f1\u3001\u7d48\u91ce\u5065\u4e00\u3001\u4e09\u6a39\u7950\u5b50\u3001\u5185\u85e4\u6ecb\u4eba
                                \n<\/span>\u7d4c\u76ae\u7684\u5de6\u5fc3\u8033\u9589\u9396\u7642\u6cd5\u8853\u4e2d\u306b\u30c7\u30d0\u30a4\u30b9\u306b\u4ed8\u7740\u3059\u308b\u53ef\u52d5\u6027\u8840\u6813\u3092\u8a8d\u3081\u305f\uff12\u4f8b<\/li>\n
                              10. \u77f3\u4e95\u79c0\u6a39\u3000
                                \n<\/span>\u30a2\u30eb\u30d6\u30df\u30f3\u5c3f\u3068CKD<\/span>\u65e9\u671f\u6cbb\u7642\u4ecb\u5165\uff5e\u5fc3\u814e\u9023\u95a2\u306b\u304a\u3051\u308bMRA<\/span>\u306e\u65b0\u305f\u306a\u5c55\u958b\u20152025<\/span>\u5e74\u554f\u984c\u3092\u76ee\u524d\u306b\u63a7\u3048\u3066\u30fc\u5faa\u74b0\u5668\u75be\u60a3\u306e\u5c55\u671b\u2015<\/li>\n<\/ol>\n

                                \u7b2c72<\/span>\u56de\u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002024.9.27-29<\/span>\uff08\u4ed9\u53f0\uff09
                                \n<\/span><\/h4>\n
                                  \n
                                1. \u9577\u5742\u5d07\u53f8
                                  \n<\/span>\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02 <\/span>\u300cSHD<\/span>\u6cbb\u7642\u306e\u6700\u524d\u7dda\u300d\uff1aParavalvular leak<\/span>\u306b\u5bfe\u3057\u3066Balloon-expandable valve<\/span>\u3092\u7528\u3044\u305fTAVR-in-TAVR<\/span>\u306e\u6709\u7528\u6027<\/li>\n
                                2. \u9ad8\u9593\u5178\u660e
                                  \n<\/span>\u6559\u80b2\u8b1b\u6f14\uff19\uff1a\u80ba\u9ad8\u8840\u5727\u75c7\u8a3a\u7642\u306e\u6700\u65b0\u6cbb\u9a13<\/li>\n
                                3. \u77f3\u5c3e\u6d35\u4e00\u90ce
                                  \n<\/span>\u30dd\u30b9\u30bf\u30fc\u300c\u5fc3\u7b4b\u708e\u300d\uff1a\u6025\u6027\u671f\u6cbb\u7642\u306blmpella CP<\/span>\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u304c \u7d4c\u904e\u4e2d\u306b\u5fc3\u5ba4\u6027\u4e0d\u6574\u8108\u3092\u8a8d\u3081\u7740\u7528\u578b\u81ea\u52d5\u9664\u7d30\u52d5\u5668\u3092\u5c0e\u5165\u3057\u9000\u9662\u3057\u305f\u5287\u75c7\u578b\u5fc3\u7b4b\u708e\u306e1<\/span>\u4f8b<\/li>\n
                                4. \u77f3\u4e95\u79c0\u6a39
                                  \n<\/span>\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff12\uff1aISCHEMIA<\/span>\u8a66\u9a13\u306f\u5954\u653e\u306ePCI<\/span>\u306b\u5fdc\u7528\u3067\u304d\u308b\u304b\uff1f<\/li>\n
                                5. \u5c0f\u4fdd\u65b9\u3000\u512a
                                  \n<\/span>\u30b9\u30dd\u30f3\u30b5\u30fc\u30c9\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff12\uff1aHFpEF<\/span>\u306e\u9069\u5207\u306a\u8a3a\u65ad\u306b\u3080\u3051\u3066\uff62HFpEF<\/span>\uff5eoverview<\/span>\u3068\u8a3a\u65ad\u306e\u8ab2\u984c\u30fb\u89e3\u6c7a\u7b56\uff5e\u300d<\/li>\n
                                6. \u5c0f\u4fdd\u65b9\u3000\u512a
                                  \n<\/span>\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc3<\/span>\uff1aHFpEF<\/span>\u306e\u8a3a\u65ad\u30fb\u6cbb\u7642Up-to-date <\/span>\u301cSGLT2i<\/span>\u3078\u306e\u671f\u5f85\uff5e<\/li>\n
                                7. \u5b89\u9054\u4ec1
                                  \n<\/span>\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc16<\/span>\uff1a\u5fc3\u4e0d\u5168\u306e\u5fc3\u81d3\uff98\uff8a\uff8b\uff9e\uff98\uff83\uff70\uff7c\uff6e\uff9d\u30fc\u30d9\u30ea\u30ad\u30e5\u30fc\u30dc\u3068\u306e\u30de\u30c3\u30c1\u30f3\u30b0\u30fc<\/li>\n
                                8. \u4e45\u91ce\u8cb4\u5f18
                                  \n<\/span>\u5fc3\u81d3AL<\/span>\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306b\u5bfe\u3059\u308b\u30c0\u30e9\u30c4\u30e0\u30de\u30d6\u306e\u6cbb\u7642\u52b9\u679c<\/li>\n<\/ol>\n

                                  \u30ab\u30c6\u30fc\u30c6\u30eb\u30a2\u30d6\u30ec\u30fc\u30b7\u30e7\u30f3\u95a2\u9023\u79cb\u5b63\u5927\u4f1a2024<\/span>\u30002024.10.11<\/span>\uff08\u5927\u962a\uff09<\/h4>\n
                                    \n
                                  1. \u91d1\u53e4\u5584\u660e
                                    \nFast pathway\u304cbystander<\/span>\u3068\u78ba\u8a8d\u3055\u308c\u305f<\/span>superior slow pathway<\/span>\u3092\u9006\u4f1d\u5c0e\u8def\u3068\u3059\u308b<\/span> slow-slow AVNRT<\/span>\u306e<\/span>1<\/span>\u4f8b\uff0e<\/span><\/li>\n
                                  2. \u4e2d\u8c37\u6d0b\u4ecb
                                    \nShort atrioventricular Mahaim pathway<\/span>\u8d77\u6e90\u306e\u81ea\u52d5\u80fd\u3068\u7570\u6240\u6027\u5fc3\u623f\u8abf\u5f8b\u3084\u671f\u5916\u53ce\u7e2e\u3068\u306e \u7af6\u5408\u306b\u3088\u308a\u69d8\u3005\u306a\u7a0b\u5ea6\u306e\u65e9\u671f\u8208\u596e\u3092\u5448\u3057\u305f1<\/span>\u4f8b \uff0e<\/li>\n
                                  3. \u7530\u6751\u5cfb\u592a\u90ce<\/li>\n<\/ol>\n
                                      <\/ol>\n

                                      \u53f3\u623f\u3078\u306e\u8907\u6570\u306ebreakthrough site<\/span>\u3092\u6709\u3057\u305f\u975e\u901a\u5e38\u578b\u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e1<\/span>\u4f8b\u00a0<\/span><\/p>\n

                                      \u7b2c64<\/span>\u56de\u57fc\u7389\u4e0d\u6574\u8108\u30da\u30fc\u30b7\u30f3\u30b0\u7814\u7a76\u4f1a\u30002024.11.30<\/span>\uff08\u3055\u3044\u305f\u307e\uff09<\/h4>\n
                                        \n
                                      1. \u5c0f\u91dd\u5c2d\u53f8\u3001\u4e2d\u8c37\u6d0b\u4ecb\u3001\u7530\u6751\u5cfb\u592a\u90ce\u3001\u9577\u8c37\u5ddd \u5bdb\u3001\u91d1\u53e4\u5584\u660e\u3001\u77f3\u4e95\u79c0\u6a39
                                        \n<\/span>\u5f8c\u58c1\u9694\u96e2\u306e\u5fc3\u5916\u819c\u5074\u30d0\u30a4\u30d1\u30b9\u3092\u4f34\u3046\u5de6\u623f\u5929\u84cb\u90e8\u4f9d\u5b58\u6027\u5fc3\u623f\u983b\u62cd\u306b\u5de6\u5fc3\u8033\u3078\u306e\u4f1d\u5c0e\u9045\u5ef6\u3092\u5408\u4f75\u3057\u305f1<\/span>\u4f8b<\/li>\n
                                      2. \u91d1\u53e4\u5584\u660e
                                        \ncompact node<\/span>\u96fb\u4f4d\u306e\u6319\u52d5\u304b\u3089\u9006\u4f1d\u5c0e\u8def\u304cfast pathway<\/span>\u304bsuperior slow pathway<\/span>\u304b\u3092\u63a8\u5b9a\u3057\u305f\u4e00\u4f8b<\/li>\n<\/ol>\n

                                        \u7b2c274<\/span>\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\u30002024.12.14<\/span>\uff08\u6771\u4eac\uff09<\/h4>\n
                                          \n
                                        1. \u4e0b\u8c37\u3000\u5e78\u3001\u6e6f\u6d45\u76f4\u7d00\u3001\u6751\u4e0a\u6587\u5d07\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u77f3\u4e95\u79c0\u6a39\u3001\u5c0f\u4fdd\u65b9\u512a
                                          \nHFpEF<\/span>\u60a3\u8005\u306b\u304a\u3051\u308b\u4e0a\u8155\u5468\u56f2\u5f84\u3068\u6804\u990a\u6307\u6a19\u3001\u904b\u52d5\u8010\u5bb9\u80fd\u3001\u4e88\u5f8c\u3068\u306e\u95a2\u9023<\/li>\n
                                        2. \u5ca9\u6df5\u3000\u821e\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u77f3\u5c3e\u6d35\u4e00\u90ce\u3001\u5929\u5185\u58eb\u90ce\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u77f3\u4e95\u79c0\u6a39
                                          \nV<\/span>\uff0dV ECMO<\/span>\u30b5\u30dd\u30fc\u30c8\u4e0b\u306b\u8d77\u52d5\u78ba\u4fdd\u3057\u624b\u8853\u3092\u884c\u3063\u305f\u3001\u826f\u6027\u5de8\u5927\u7532\u72b6\u817a\u816b\u760d\u306e\u4e00\u4f8b<\/li>\n
                                        3. \u702c\u7530\u535a\u8cb4\u3001\u5927\u99d2\u76f4\u4e5f\u3001\u67f4\u7530\u609f\u3001\u7fbd\u9ce5\u76f4\u6a39\u3001\u9ad8\u6a4b\u4f38\u5f25\u3001\u5c0f\u6797\u7d18\u751f\u3001\u6751\u7530\u667a\u884c\u3001\u592a\u7530\u660c\u6a39\u3001\u798f\u7530\u5ef6\u662d\u3001\u5e83\u4e95\u77e5\u6b73
                                          \n<\/span>\u30d4\u30eb\u30e1\u30ce\u30fc\u30eb\u4e2d\u6bd2\u306b\u3088\u308b\u5fc3\u5ba4\u983b\u62cd\u306b\u5bfe\u3057\u3066\u4e00\u6642\u7684\u30da\u30fc\u30b7\u30f3\u30b0\u304c\u6709\u52b9\u3067\u3042\u3063\u305f\u4e00\u4f8b<\/li>\n
                                        4. \u5b89\u85e4\u548c\u79c0\u3001\u5cef\u5cb8\u7f8e\u667a\u5b50\u3001\u68b6\u539f\u5553\u543e\u3001\u4e94\u5341\u5d50\u5b8f\u4f38\u3001\u5150\u7389\u667a\u83ef\u3001\u897f\u5c3e\u7406\u6c99\u3001\u5bcc\u6fa4\u7f8e\u590f\u3001\u5ca1\u7530\u82f1\u6a39\u3001\u4f50\u3005\u6728\u5b5d\u5fd7\u3001\u5c0f\u6797\u6d0b\u660e\u3001\u5ead\u524d\u91ce\u83ca
                                          \n<\/span>\u7d4c\u30ab\u30c6\u30fc\u30c6\u30eb\u5927\u52d5\u8108\u5f01\u690d\u8fbc\u307f\u8853\u5f8c\u306b\u3001\u6eb6\u8840\u6027\u8ca7\u8840\u3068\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u585e\u6813\u3092\u751f\u3058\u30b9\u30c6\u30ed\u30a4\u30c9\u304c\u8457\u52b9\u3057\u305f\uff11\u4f8b<\/li>\n
                                        5. \u6c38\u4e95\u826f\u4e09
                                          \n<\/span>\u5185\u95a3\u5e9cSIP<\/span>\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\uff1a\u533b\u7642\u30d3\u30c3\u30b0\u30c7\u30fc\u30bf\u30b7\u30b9\u30c6\u30e0\u30fb\u533b\u7642AI<\/span>\u306e\u73fe\u72b6\u3068\u8ab2\u984c<\/li>\n<\/ol>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

                                          \u7b2c25\u56de\u65e5\u672c\u6210\u4eba\u5148\u5929\u6027\u5fc3\u75be\u60a3\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a2024.1.6-8\uff08\u6771\u4eac\uff09 \u5c0f\u677f\u6a4b\u7d00\u901a \u598a\u5a20\u4e2d\u306b\u4e73\u304c\u3093\u306b\u96c6\u5b66\u7684\u6cbb\u7642\u3092\u884c\u3063\u305f\u30d5\u30a1\u30ed\u30fc\u56db\u5fb4\u75c7\u8853\u5f8c\u598a\u5a66\u306e\u4e00\u4f8b \u5409\u7530\u304f\u306b\u5b50 \u8457\u660e\u306a\u53f3\u623f\u5316\u53f3\u5ba4\u3092\u4f34\u3046\u30a8\u30d6\u30b9\u30bf\u30a4\u30f3\u5947\u5f62\u598a\u5a66\u306e\u4e00\u4f8b \u7530\u6751\u5cfb […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":972,"menu_order":34,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-974","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=974"}],"version-history":[{"count":6,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/974\/revisions"}],"predecessor-version":[{"id":986,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/974\/revisions\/986"}],"up":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/972"}],"wp:attachment":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}